|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 15, 2017 ) According to the report Global Cancer Vaccines Market, published by Market Data Forecast, the Global market is projected to reach USD 7.34 billion by 2022, at a CAGR of 17.11% from 2017 to 2022.
Cancer vaccines treat patients with cancer and prevents the further development of the cancer. It is also used for the prevention of contagious diseases by improving immune systems against new pathogens. Researchers developed cancer therapeutic vaccines to alleviate patients suffering from cancer. The new technological advances which developed a new therapeutic way for cancer is showcasing the market growth.
Get a comprehensive overview of the Global Cancer Vaccines Market: http://www.marketdataforecast.com/market-reports/global-cancer-vaccines-market-1419/
Global Cancer Vaccines Market: Drivers & Restraints
The Global Cancer Vaccines Market is driven by the rising number of people with cancer, increasing public awareness of vaccines, smoking and excessive alcoholic intake, presence of strong late-stage pipeline vaccines and vendors patient-assistance programs. The factors that are hampering the growth of the market are vaccines costs and stringent regulations for the approval.
Get accurate market forecast and analysis on the Global Cancer Vaccines Market. Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/global-cancer-vaccines-market-1419/request-sample
Global Cancer Vaccines Market: Segmentation
By Treatment type
Prophylactic
Therapeutic
By Cancer Type
Prostate Cancer
Cervical Cancer
Colorectal Cancer
Throat Cancer
Others
By Vaccine Type
Tumour cell Vaccines
Protein or Peptide Vaccines
Genetic Vaccines
Dendritic cell Vaccines
Other Vaccines
By End Users
Cancer Treatment Centres
Research Institutes
By Geography
North America
o United States
o Canada
Europe
o U.K
o Spain
o Germany
o Italy
o France
Asia-Pacific
o China
o India
o Japan
o Australia
o South Korea
Latin America
o Brazil
o Argentina
o Mexico
o Rest of Latin America
Middle East & Africa
o Middle-East
o Africa
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at http://www.marketdataforecast.com/market-reports/global-cancer-vaccines-market-1419/customize-report
Global Cancer Vaccines Market: Overview
In 2017, prostate cancer accounted for the largest share in terms of revenue and throat cancer is anticipated to have fastest growing rate due to the rise in consumption of cigarettes. In vaccine type, tumour cell vaccines are expected to have the highest share due to the rise in chronic diseases like cancer. In end-user, cancer treatment centres expected to have the largest share in the global market.
The Global Cancer Vaccines Market is dominated by North America in 2017 with the region accounting for 33% of the overall market share owing to increased rates of cancer deaths and escalating awareness about the cancer by government increases patients treatment. Asia-Pacific is expected to grow rapidly in the coming due to increased healthcare expenditure in developing countries in this region.
Global Cancer Vaccines Market: Key Players
Key major companies in the global cancer vaccines market are GlaxoSmithKline, Dendreon and Merck. Other companies wwith pipeline stage are Advaxis, Agenus, Aduro Biotech, Advantagene, ISA Pharmaceuticals, Juvaris Biotherapeutics, Altor BioScience, Argos Therapeutics, AVAX Technologies, Bavarian Nordic, Biothera, OncoThyreon, Oncovir, Celldex Therapeutics, CureVac, Northwest Biotherapeutics, NovaRx, Galena Biopharma, Genexine, Oxford BioMedica, Prsima BioMed, GlobeImmune, Sotio, Transgene, Gradalis, Heat Biologics, Immatics, ImmunoCellular Therapeutics, Inovio Pharmaceuticals, NewLink Genetics, Ubivac, Vaccinogen and Vaxon Biotech.
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
